DE69626040D1 - 3-deoxy-3-descladinosederivate von erythromycin a und b - Google Patents

3-deoxy-3-descladinosederivate von erythromycin a und b

Info

Publication number
DE69626040D1
DE69626040D1 DE69626040T DE69626040T DE69626040D1 DE 69626040 D1 DE69626040 D1 DE 69626040D1 DE 69626040 T DE69626040 T DE 69626040T DE 69626040 T DE69626040 T DE 69626040T DE 69626040 D1 DE69626040 D1 DE 69626040D1
Authority
DE
Germany
Prior art keywords
descladinose
erythromycin
deoxy
derivatives
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69626040T
Other languages
English (en)
Other versions
DE69626040T2 (de
Inventor
Sun Or
T Chu
L Elliott
Daisy Pireh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/729,269 external-priority patent/US5747466A/en
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69626040D1 publication Critical patent/DE69626040D1/de
Application granted granted Critical
Publication of DE69626040T2 publication Critical patent/DE69626040T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69626040T 1995-11-08 1996-11-06 3-deoxy-3-descladinosederivate von erythromycin a und b Expired - Fee Related DE69626040T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US634295P 1995-11-08 1995-11-08
US6342P 1995-11-08
US08/729,269 US5747466A (en) 1995-11-08 1996-10-10 3-deoxy-3-descladinose derivatives of erythromycins A and B
US729269 1996-10-10
PCT/US1996/017892 WO1997017357A1 (en) 1995-11-08 1996-11-06 3-deoxy-3-descladinose derivatives of erythromycins a and b

Publications (2)

Publication Number Publication Date
DE69626040D1 true DE69626040D1 (de) 2003-03-06
DE69626040T2 DE69626040T2 (de) 2004-01-22

Family

ID=26675509

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69626040T Expired - Fee Related DE69626040T2 (de) 1995-11-08 1996-11-06 3-deoxy-3-descladinosederivate von erythromycin a und b

Country Status (13)

Country Link
EP (1) EP0874863B1 (de)
JP (1) JP2000501077A (de)
KR (1) KR19990067333A (de)
AT (1) ATE231878T1 (de)
AU (1) AU714176B2 (de)
CA (1) CA2235681A1 (de)
DE (1) DE69626040T2 (de)
DK (1) DK0874863T3 (de)
ES (1) ES2191778T3 (de)
IL (1) IL123386A0 (de)
MX (1) MX9803694A (de)
PT (1) PT874863E (de)
WO (1) WO1997017357A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757518B1 (fr) * 1996-12-23 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
US5523399A (en) * 1991-12-27 1996-06-04 Taisho Pharmaceutical Co., Ltd. 5-O-desosaminylerythronolide derivatives

Also Published As

Publication number Publication date
AU714176B2 (en) 1999-12-23
WO1997017357A1 (en) 1997-05-15
IL123386A0 (en) 1998-09-24
ES2191778T3 (es) 2003-09-16
MX9803694A (es) 1998-09-30
DE69626040T2 (de) 2004-01-22
CA2235681A1 (en) 1997-05-15
AU1074497A (en) 1997-05-29
EP0874863A1 (de) 1998-11-04
KR19990067333A (ko) 1999-08-16
JP2000501077A (ja) 2000-02-02
ATE231878T1 (de) 2003-02-15
DK0874863T3 (da) 2003-05-26
EP0874863B1 (de) 2003-01-29
PT874863E (pt) 2003-06-30

Similar Documents

Publication Publication Date Title
EA199901016A1 (ru) 9-оксим-производные эритромицина
DE69720551D1 (de) Makrozyklische derivate von erythromycin a und b mit 13 ringatomen
FI951468A0 (fi) Lipopeptidijohdannaiset, menetelmä niiden valmistamiseksi ja niiden käyttö
ATE255589T1 (de) Kristallin form i von clarithromycin
FI113644B (fi) Menetelmä terapeuttisesti aktiivisten N-substituoitujen 3- atsabisykloalkaanijohdannaisten valmistamiseksi
AU544790B2 (en) Epimeric azahomoerythromycin a derivatives
PT876388E (pt) Derivados de eritromicina triciclica
TR200200436T2 (tr) Yeni makrolit antibiyotikler
GT199900208A (es) Antibiòticos cetòlidos carbamato y carbazato.
DK1007530T3 (da) 6-O-substituerede erythromycinforbindelser samt fremgangsmåde til fremstilling heraf
MX9708611A (es) Compuestos de dialquiltiacumicina.
FI960658A0 (fi) Uudet bis-naftalimidit syövän hoitamiseksi
MD1788F2 (en) Erythromycin A 9-O-oximes derivatives, pharmaceutical composition on base thereof and method of treatment of infectious diseases
ATE231878T1 (de) 3-deoxy-3-descladinosederivate von erythromycin a und b
ATE42305T1 (de) Antibiotika, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
PT777471E (pt) Metodo de inibicao da biosintese de leucotrieno
RU93055684A (ru) Соединения, ингибирующие вич-протеазу, способ их получения, фармацевтическая композиция, промежуточный продукт

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee